Juan Romero, MD
Ophthalmology · Great Neck, NYNPI 1447299631
Payments from drug & device makers
Across 136 payments — averaging $44.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$3K
- Regeneron Healthcare Solutions, Inc.$1K
- AbbVie$371
- Apellis Pharmaceuticals, Inc.$352
- Coherus Oncology, Inc.$211
- Mallinckrodt Hospital Products Inc.$167
- plus $756 from 9 others
What the payments were for
- Consulting fees$2,11535%
- Food & beverage$3,83263%
- Education$982%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 40 | $2,919 |
| Regeneron Healthcare Solutions, Inc. | 51 | $1,269 |
| AbbVie(2 entities) | 14 | $371 |
| Apellis Pharmaceuticals, Inc. | 7 | $352 |
| Coherus Oncology, Inc. | 6 | $211 |
| Mallinckrodt Hospital Products Inc. | 3 | $167 |
| Bausch & Lomb Americas Inc. | 1 | $150 |
| Sanofi | 1 | $120 |
| Kala Pharmaceuticals, Inc. | 1 | $119 |
| Alcon | 1 | $106 |
| Novartis | 5 | $94 |
| Eyepoint US, Inc. | 2 | $48 |
| Astellas Pharma US Inc | 2 | $48 |
| Sandoz | 1 | $47 |
| Harrow Eye, LLC | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SUSVIMO$2,115
- Syfovre$240
- enVista MX60 IOL$150
- EYLEA HD$149
- EYLEA$149
- DUPIXENT$120
- INVELTYS$119
- AcrySof IQ PanOptix UV IOL$106
- AcrySof IQ VIVITY$106
How this compares
$6,045 in reported general payments places this provider in the 80th percentile of 1,587 ophthalmology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProlensaBromfenac Sodium | 30 | $10,417 |
| Bromfenac Sodium | 43 | $7,395 |
| Prednisolone Acetate | 158 | $7,112 |
| Loteprednol Etabonate | 29 | $4,304 |
| Brimonidine Tartrate | 40 | $2,942 |
| Difluprednate | 15 | $1,290 |
| Ketorolac Tromethamine | 42 | $1,026 |
| Ofloxacin | 57 | $853 |
| Latanoprost | 37 | $277 |
| ErythromycinErythromycin Base | 22 | $254 |
| Dorzolamide Hcl | 13 | $186 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 11 | $165 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 17 | $137 |
| Timolol Maleate | 12 | $115 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Great Neck
- Philip FerroneGreat Neck$5.8M
- Jonathan JonischGreat Neck$1M
- Kenneth GrahamGreat Neck$959K
- David RheeGreat Neck$699K
- Brett RosenblattGreat Neck$676K
- Douglas JabsNew York$24.3M
- David RubaltelliBrooklyn$8.9M
- Eric DonnenfeldGarden City$2.6M
- Nathan RadcliffeNew York$2.4M
- Glenn StollerRockville Centre$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.